News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
714,025 Results
Type
Article (43346)
Company Profile (353)
Press Release (670326)
Section
Business (211559)
Career Advice (2079)
Deals (36340)
Drug Delivery (90)
Drug Development (82047)
Employer Resources (172)
FDA (16642)
Job Trends (15269)
News (355502)
Policy (33312)
Tag
Academia (2683)
Alliances (52107)
Alzheimer's disease (1251)
Approvals (16572)
Artificial intelligence (150)
Bankruptcy (357)
Best Places to Work (11828)
Biotechnology (252)
Breast cancer (122)
Cancer (1105)
Cardiovascular disease (98)
Career advice (1739)
Cell therapy (248)
Clinical research (65030)
Collaboration (405)
Compensation (202)
COVID-19 (2615)
C-suite (100)
Data (1142)
Diabetes (153)
Diagnostics (6406)
Earnings (86423)
Employer resources (151)
Events (114126)
Executive appointments (320)
FDA (17193)
Funding (367)
Gene therapy (188)
GLP-1 (595)
Government (4427)
Healthcare (19384)
Infectious disease (2702)
Inflammatory bowel disease (109)
Interviews (319)
IPO (16638)
Job creations (3813)
Job search strategy (1488)
Layoffs (425)
Legal (8072)
Lung cancer (173)
Manufacturing (180)
Medical device (13901)
Medtech (13906)
Mergers & acquisitions (19781)
Metabolic disorders (410)
Neuroscience (1531)
NextGen Class of 2024 (6831)
Non-profit (4601)
Northern California (1499)
Obesity (234)
Opinion (190)
Patents (108)
People (58476)
Phase I (20351)
Phase II (28624)
Phase III (21254)
Pipeline (460)
Postmarket research (2572)
Preclinical (8748)
Radiopharmaceuticals (254)
Rare diseases (225)
Real estate (6216)
Regulatory (22097)
Research institute (2448)
Resumes & cover letters (360)
Southern California (1323)
Startups (3827)
United States (13849)
Vaccines (578)
Weight loss (173)
Date
Today (108)
Last 7 days (705)
Last 30 days (3782)
Last 365 days (36701)
2024 (33664)
2023 (41134)
2022 (52398)
2021 (56996)
2020 (55616)
2019 (48410)
2018 (36442)
2017 (33541)
2016 (33139)
2015 (39358)
2014 (32941)
2013 (27985)
2012 (30243)
2011 (30847)
2010 (28809)
Location
Africa (754)
Arizona (201)
Asia (39771)
Australia (6608)
California (3394)
Canada (1300)
China (255)
Colorado (152)
Connecticut (158)
Europe (86862)
Florida (464)
Georgia (124)
Illinois (361)
Indiana (202)
Kansas (99)
Maryland (588)
Massachusetts (2690)
Michigan (173)
Minnesota (281)
New Jersey (974)
New York (971)
North Carolina (743)
Northern California (1499)
Ohio (141)
Pennsylvania (854)
South America (1149)
Southern California (1323)
Texas (474)
Utah (95)
Washington State (373)
714,025 Results for "jenavalve technology inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
JenaValve’s Trilogy THV System Highlighted at CRT 2024
JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve System, announced highlights from the Cardiovascular Research Technologies Conference 2024.
March 19, 2024
·
2 min read
Biotech Beach
egnite, Inc. and JenaValve Announce Novel Research on Outcomes with Untreated Aortic Regurgitation at the 2024 American College of Cardiology Conference
egnite, Inc., a leading digital health company for cardiovascular care, and JenaValve Technology, Inc., a developer and manufacturer of differentiated transcatheter aortic valve replacement systems, unveil a novel study presented at the American College of Cardiology’s Annual Scientific Session & Expo.
April 6, 2024
·
4 min read
Biotech Beach
JenaValve Announces Publication of ALIGN-AR Pivotal Trial Results in The Lancet
JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced the publication of results from the ALIGN-AR Pivotal Trial in The Lancet.
March 28, 2024
·
4 min read
Press Releases
JenaValve Presents ALIGN-AR 2-Year Follow-Up Data at TCT 2024 and Announces Commencement of ARTIST Randomized Controlled Trial (RCT)
November 13, 2024
·
3 min read
Biotech Beach
JenaValve Featured at the PCR London Valves 2023
JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve System, announced highlights from PCR London Valves 2023, a leading, annual global valve conference.
December 6, 2023
·
2 min read
Business
JenaValve Appoints Shlomi Nachman to Board of Directors
JenaValve Technology, Inc. announced that it has appointed Shlomi Nachman, experienced cardiovascular industry executive, to its Board of Directors.
September 14, 2023
·
3 min read
Biotech Beach
JenaValve Announces Partnership with the American Society of Echocardiography (ASE) to Advance Detection and Diagnosis of Aortic Regurgitation
JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced that it will join the American Society of Echocardiography (ASE) Industry Roundtable in 2024.
November 16, 2023
·
2 min read
Biotech Beach
egnite, Inc. and JenaValve Announce Strategic Partnership to Uncover Trends in Care for Patients with Aortic Regurgitation
egnite, Inc. and JenaValve Technology, Inc. are pleased to announce a strategic partnership aimed to shed light on the care paradigm and associated outcomes of patients with aortic regurgitation.
June 9, 2023
·
4 min read
Biotech Beach
JenaValve Announces Late-Breaking Data from the ALIGN-AR Pivotal Trial Meeting Safety and Efficacy Endpoints
JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced results from the ALIGN-AR Pivotal Trial for the Trilogy THV System in high-risk patients with symptomatic, severe aortic regurgitation (AR).
October 24, 2023
·
3 min read
Biotech Beach
JenaValve Announces First Trilogy Heart Valve Systems Implanted in Asia
JenaValve Technology, Inc., developer and manufacturer of differentiated transcatheter aortic valve replacement systems, announced the completion of the first two Trilogy Heart Valve System implantations in Asia.
May 18, 2023
·
3 min read
1 of 71,403
Next
